Neuropathological changes correlate temporally but not spatially with selected neuromodulatory responses in natural scrapie

Neuropathology and Applied Neurobiology

Volumn 37, Issue 5, 2011, Pages 484-499

  Sisó, Sílvia ^a   Gonzalez L ^a   Blanco, R ^c   Chianini, F ^b   Reid, H W ^b   Jeffrey, M ^a   Ferrer, I ^c  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Neuromodulation; Neuropathology; Preclinical; Prion; Sheep; Transmissible spongiform encephalopathy

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENYLATE CYCLASE; ADENYLATE CYCLASE 1; METABOTROPIC RECEPTOR 1; PARVALBUMIN; PHOSPHOLIPASE C BETA1; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BIOCHEMISTRY; BOVINE SPONGIFORM ENCEPHALOPATHY; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SCRAPIE; SHEEP;

ANIMALS; BLOTTING, WESTERN; BRAIN; IMMUNOHISTOCHEMISTRY; RECEPTOR, ADENOSINE A1; RECEPTORS, METABOTROPIC GLUTAMATE; SCRAPIE; SHEEP;

EID: 79960259700     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2010.01152.x     Document Type: Article

References (57)

1. Prusiner SB. The prion diseases of humans and animals. In The Molecular and Genetic Basis of Neurological Diseases. Eds RN Rosenber, SB Prusiner, S DiMauro, RL Barchi. Boston, MA: Butterworth-Heinemann, 1997; 165-86.
2. Aguzzi A. Introduction to prion diseases. In Neurodegeneration: The Molecular Pathlogy of Dementia and Movement Disorders. Ed. DW Dickson. Basel: ISN Neuropath Press, 2003; 282-9.
3. Budka H, Head MW, Ironside JW, Gambetti P, Parchi P, Zeidler M, Tagliavini F. Sporadic Creutzfeldt-Jakob disease. In Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Ed. DW Dickson. Basel: ISN Neuropath Press, 2003; 287-97.
4. DeArmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. In Greenfield's Neuropathology, Vol II. Eds DI Graham, PL Lantos. London: Arnold, 2003; 273-323.
5. Gambetti P, Parchi P, Chen SG, Cortelli P, Lugaresi E, Montagna P. Fatal insomnia: familial and sporadic. In Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Ed. DW Dickson. Basel: ISN Neuropath Press, 2003; 326-32.
6. Ghetti B, Bugiani O, Tagliavini F, Piccardo P. Gerstmann-Sträussler-Scheinker disease. In Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Ed. DW Dickson. Basel: ISN Neuropath Press, 2003; 318-25.
7. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-44.
8. DeArmond SJ, Ironside JW. Neuropathology of prion diseases. In Prion Biology and Diseases. Ed. SB Prusiner. New York: Cold Spring Harbor Laboratory Press, 1999; 585-652.
9. Jeffrey M, González L. Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathol Appl Neurobiol 2007; 33: 373-94.
10. Sisó S, Jeffrey M, González L. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route. Neuropathol Appl Neurobiol 2009; 35: 232-46.
11. González L, Martin S, Hawkins SA, Goldmann W, Jeffrey M, Sisó S. Pathogenesis of natural goat scrapie: modulation by host PRNP genotype and effect of co-existent conditions. Vet Res 2010; 41: 48.
12. Begara-McGorum I, González L, Simmons M, Hunter N, Houston F, Jeffrey M. Vacuolar lesion profile in sheep scrapie: factors influencing its variation and relationship to disease-specific PrP accumulation. J Comp Pathol 2002; 127: 59-68.
13. González L, Martin S, Begara-McGorum I, Hunter N, Houston F, Simmons M, Jeffrey M. Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie. J Comp Pathol 2002; 126: 17-29.
14. Konold T, Bone GE, Phelan LJ, Simmons MM, González L, Sisó S, Goldmann W, Cawthraw S, Hawkins SA. Monitoring of clinical signs in goats with transmissible spongiform encephalopathies. BMC Vet Res 2010; 6: 13.
15. Ironside JW. Prion diseases in man. J Pathol 1998; 86: 227-34.
16. Knight RSG, Will RG. Prion diseases. J Neurol Neurosurg Psychiatry 2004; 75: S136-42.
17. Ferrer I, Casas R, Rivera R. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease. Ann Neurol 1993; 34: 864-66.
18. Guentchev M, Hainfellner JA, Trabattoni GR, Budka H. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1997; 56: 1119-24.
19. Belichenko PV, Miklossy J, Belser B, Budka H, Celio MR. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease. Neurobiol Dis 1999; 6: 269-79.
20. Guentchev M, Groschup MH, Kordek R, Liberski PP, Budka H. Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 1998; 8: 615-23.
21. Vidal E, Bolea R, Tortosa R, Costa C, Domènech A, Monleón E, Vargas A, Badiola JJ, Pumarola M. Assessment of calcium-binding proteins (Parvalbumin and Calbindin D-28K) and perineuronal nets in normal and scrapie-affected adult sheep brains. J Virol Methods 2006; 136: 137-46.
22. Giese A, Kretzschmar HA. Prion-induced neuronal damage: the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr Top Microbiol Immunol 2001; 253: 203-17.
23. Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, Sayers AR, Brown DA, Fraser JR. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 2000; 26: 41-54.
24. Jeffrey M, Fraser JR, Halliday BWG, Fowler N, Goodsir CM, Brown DA. Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunohistochemistry. Neuropathol Appl Neurobiol 1995; 21: 41-9.
25. Sisó S, Puig B, Varea R, Vidal E, Acín C, Prinz M, Montrasio F, Badiola J, Aguzzi A, Pumarola M, Ferrer I. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol 2002; 103: 615-26.
26. Siskova Z, Page A, O'Connor V, Perry VH. Degenerating synaptic boutons in prion disease. Am J Pathol 2009; 175: 1610-21.
27. Gray BC, Siskova Z, Perry VH, O'Connor V. Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology. Neurobiol Dis 2009; 35: 63-74.
28. Landis DM, Williams RS, Masters CL. Golgi and electronmicroscopic studies of spongiform encephalopathies. Neurology 1981; 31: 538-49.
29. Ferrer I, Costa F, Grau Veciana JM. Creutzfeldt-Jakob disease: a Golgi study. Neuropathol Appl Neurobiol 1981; 7: 237-42.
30. Ferrer I, Guionnet N, Cruz-Sánchez F, Tuñón T. Neuronal alterations in patients with dementia: a Golgi study on biopsy samples. Neurosci Lett 1990; 114: 11-16.
31. Clinton J, Forsyth C, Royston MC, Roberts GW. Synaptic degeneration is the primary neuropathological feature in prion diseases: a preliminary study. Neuroreport 1993; 4: 65-8.
32. Ferrer I, Rivera R, Blanco R, Martí E. Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease. Neurobiol Dis 1999; 6: 92-100.
33. Ferrer I, Puig B, Blanco R, Martí E. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease. Neuroscience 2000; 97: 715-26.
34. A receptors in Creutzfeldt-Jakob disease. Acta Neuropathol 2003; 106: 311-18.
35. Ferrer I. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. Cerebellum 2002; 1: 213-22.
36. Rodríguez A, Freixes M, Dalfó E, Martín M, Puig B, Ferrer I. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex. Neuroscience 2005; 131: 825-32.
37. Rodríguez A, Martín M, Albasanz JL, Barrachina M, Espinosa JC, Torres JM, Ferrer I. Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice. Neurosci Lett 2006; 410: 115-20.
38. Jeffrey M, Martin S, Thomson JR, Dingwall WS, Begara-McGorum I, González L. Onset and distribution of tissue PrP accumulation in scrapie-affected Suffolk sheep as demonstrated by sequential necropsies and tonsillar biopsies. J Comp Pathol 2001; 125: 48-57.
39. González L, Dagleish MP, Martin S, Dexter G, Steele P, Finlayson J, Jeffrey M. Diagnosis of preclinical scrapie in live sheep by the immunohistochemical examination of rectal biopsies. Vet Rec 2008; 162: 397-403.
40. González L, Martin S, Houston FE, Hunter N, Reid HW, Bellworthy SJ, Jeffrey M. Phenotype of disease-associated PrP accumulation in the brain of bovine spongiform encephalopathy experimentally infected sheep. J Gen Virol 2005; 86: 827-38.
41. Ahmed Z, Shaw G, Sharma VP, Yang C, McGowan E, Dickson DW. Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. J Histochem Cytochem 2007; 55: 687-700.
42. Sisó S, Tort S, Aparici C, Pérez L, Vidal E, Pumarola M. Abnormal neuronal expression of the calcium-binding proteins, parvalbumin and calbindin D-28k, in aged dogs. J Comp Pathol 2003; 128: 9-14.
43. Ligios C, Jeffrey M, Ryder SJ, Bellworthy SJ, Simmons MM. Distinction of scrapie phenotypes in sheep by lesion profiling. J Comp Pathol 2002; 127: 45-57.
44. d Profiling Method. J Comp Pathol 2010; 142: 300-10.
45. Fraser H. The pathology of natural and experimental scrapie. Front Biol 1976; 44: 267-305.
46. van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA. Pathogenesis of natural scrapie in sheep. Arch Virol Suppl 2000; 16: 57-71.
47. Jeffrey M, Martin S, Barr J, Chong A, Fraser JR. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol 2001; 124: 20-8.
48. Vidal E, Acín C, Foradada L, Monzón M, Márquez M, Monleón E, Pumarola M, Badiola JJ, Bolea R. Immunohistochemical characterisation of classical scrapie neuropathology in sheep. J Comp Pathol 2009; 141: 135-46.
49. d immunoreactivity in the brain of scrapie- and BSE-infected sheep: implications for differential cell targeting and PrP processing. J Gen Virol 2003; 84: 1339-50.
50. Jeffrey M, McGovern G, Goodsir CM, Sisó S, González L. Strain-associated variations in abnormal PrP trafficking of sheep scrapie. Brain Pathol 2009; 19: 1-11.
51. Ersdal C, Simmons MM, Goodsir C, Martin S, Jeffrey M. Sub-cellular pathology of scrapie: coated pits are increased in PrP codon 136 alanine homozygous scrapie-affected sheep. Acta Neuropathol 2003; 103: 17-28.
52. Andressen C, Blümcke I, Celio MR. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 1993; 271: 181-208.
53. Tschampa HJ, Herms JW, Schulz-Schaeffer WJ, Maruschak B, Windl O, Jastrow U, Zerr I, Steinhoff BJ, Poser S, Kretzschmar HA. Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain 2002; 125: 2558-66.
54. Ford MJ, Burton LJ, Li H, Graham CH, Frobert Y, Grassi J, Hall SM, Morris RJ. A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience 2002; 111: 533-51.
55. Healy AM, Weavers E, McElroy M, Gomez-Parada M, Collins JD, O'Doherty E, Sweeney T, Doherty ML. The clinical neurology of scrapie in Irish sheep. J Vet Intern Med 2003; 17: 908-16.
56. Rodríguez A, Martín M, Albasanz JL, Barrachina M, Espinosa JC, Torres JM, Ferrer I. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice. J Neuropathol Exp Neurol 2006; 65: 964-75.
57. Fredholm BB, Dunwiddie TV. How does adenosine inhibit transmitter release? Trends Pharmacol Sci 1988; 9: 130-4.